FDA tightens oversight of antibody tests for COVID-19

After initially allowing commercial manufacturers and laboratories to market self-validated antibody tests for coronavirus disease (COVID-19), the US Food and Drug Administration (FDA) says that commercial manufacturers must now submit an emergency use authorization (EUA) with validation data to continue marketing the tests.